TY  - GEN
AU  - Thomas,Philip G
AU  - Woodside,Kenneth J
AU  - Lappin,Jacqueline A
AU  - Vaidya,Smita
AU  - Rajaraman,Srinivasan
AU  - Gugliuzza,Kristene K
TI  - Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation
SN  - 0041-1337
PY  - 2007///0731
KW  - Adult
KW  - Alemtuzumab
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Antibodies, Monoclonal, Humanized
KW  - Antibodies, Neoplasm
KW  - Antilymphocyte Serum
KW  - Drug Therapy, Combination
KW  - Female
KW  - Follow-Up Studies
KW  - Graft Rejection
KW  - epidemiology
KW  - Graft Survival
KW  - Humans
KW  - Immunosuppressive Agents
KW  - therapeutic use
KW  - Incidence
KW  - Kidney Transplantation
KW  - mortality
KW  - Male
KW  - Middle Aged
KW  - Mycophenolic Acid
KW  - Risk Factors
KW  - Steroids
KW  - Tacrolimus
KW  - Transplantation Tolerance
KW  - drug effects
N1  - Publication Type: Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1097/01.tp.0000263344.53000.a1
ER  -